Kirschbaum, K., Sonner, J. K., Zeller, M. W., Deumelandt, K., Krüwel-Bode, J., Sharma, R., . . . Breckwoldt, M. O. (2016). In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 113(46), . https://doi.org/10.1073/pnas.1609397113
Chicago Style (17th ed.) CitationKirschbaum, Klara, et al. "In Vivo Nanoparticle Imaging of Innate Immune Cells Can Serve as a Marker of Disease Severity in a Model of Multiple Sclerosis." Proceedings of the National Academy of Sciences of the United States of America 113, no. 46 (2016). https://doi.org/10.1073/pnas.1609397113.
MLA (9th ed.) CitationKirschbaum, Klara, et al. "In Vivo Nanoparticle Imaging of Innate Immune Cells Can Serve as a Marker of Disease Severity in a Model of Multiple Sclerosis." Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 46, 2016, https://doi.org/10.1073/pnas.1609397113.